Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Dec;9(4):375-9.
doi: 10.4142/jvs.2008.9.4.375.

Low numbers of intestinal Shiga toxin-producing E. coli correlate with a poor prognosis in sheep infected with bovine leukemia virus

Witold A Ferens  1 , Julius Haruna, Rowland Cobbold, Carolyn J Hovde
Affiliations

Low numbers of intestinal Shiga toxin-producing E. coli correlate with a poor prognosis in sheep infected with bovine leukemia virus

Witold A Ferens et al. J Vet Sci. 2008 Dec.

Abstract

Healthy ruminants carry intestinal Shiga toxin (Stx)-producing Escherichia coli (STEC). Stx has antiviral activities in vitro and STEC numbers correlate with reduced early viremia in sheep experimentally infected with bovine leukemia virus (BLV). This study assessed the impact of intestinal STEC on BLV-induced disease for one year post-BLV-challenge. High STEC scores (CFU/g feces x frequency of STEC-positive samples) correlated with good health, whereas poor weight gain, distress, and tumor development occurred only among animals with low STEC scores. STEC carriage was associated with increased percentages of B cells in peripheral blood.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Low Shiga toxin-producing Escherichia coli (STEC) score correlated with poor health at the advanced stage of bovine leukemia virus (BLV) infection. STEC scores were calculated form 6 samples (average logarithm of CFU/g feces, multiplied by proportion of STEC- positive samples). The horizontal broken line separates low (STEC score ≤ 1.5) from high (STEC score ≥ 2.3) rank. Animals presenting with symptoms of poor health are indicated by letter "P", and letter "T" indicates an animal with tumors.
Fig. 2
Fig. 2
Weight gain in sheep challenged with bovine leukemia virus (BLV) correlated with Shiga toxin-producing Escherichia coli (STEC) scores. Weight at 6 months post BLV challenge is plotted against STEC scores. (A) BLV-challenged sheep, (B) control sheep. Points in panel A were fitted with a second-power polynomial curve.
Fig. 3
Fig. 3
Shiga toxin-producing Escherichia coli (STEC) treatment correlated with percentages of B cells in blood. Data are group averages + SEM of B cell percentages. A bracket indicates group 1 significantly different from control (ANOVA, p < 0.05).
Fig. 4
Fig. 4
Peak B-cell percentages differentially correlated with Shiga toxin-producing Escherichia coli (STEC) scores. (A) % B-cells in bovine leukemia virus (BLV)-challenged sheep were negatively correlated with STEC scores. (B) % B-cells from BLV-free control sheep were positively correlated with STEC scores.
See this image and copyright information in PMC

References

    1. Asakura H, Makino S, Shirahata T, Tsukamoto T, Kurazono H, Ikeda T, Takeshi K. Detection and genetical characterization of Shiga toxin-producing Escherichia coli from wild deer. Microbiol Immunol. 1998;42:815–822. - PubMed
    1. Bettelheim KA, Bensink JC, Tambunan HS. Serotypes of verotoxin-producing (Shiga toxin-producing) Escherichia coli isolated from healthy sheep. Comp Immunol Microbiol Infect Dis. 2000;23:1–7. - PubMed
    1. Beutin L, Geier D, Steinrück H, Zimmermann S, Scheutz F. Prevalence and some properties of verotoxin (Shiga-like toxin)-producing Escherichia coli in seven different species of healthy domestic animals. J Clin Microbiol. 1993;31:2483–2488. - PMC - PubMed
    1. Butler T, Islam MR, Azad MA, Jones PK. Risk factors for development of hemolytic uremic syndrome during shigellosis. J Pediatr. 1987;110:894–897. - PubMed
    1. Davis WC, Davis JE, Hamilton MJ. Use of monoclonal antibodies and flow cytometry to cluster and analyze leukocyte differentiation molecules. Methods Mol Biol. 1995;45:149–167. - PubMed

Publication types

MeSH terms